1. Quercetin attenuates cyclooxygenase-2 expression in response to acute ureteral obstruction.
   Inge Carlsen et al, 2015, Am J Physiol Renal Physiol CrossRef
2. Effect of hyperoside on the apoptosis of A549 human non-small cell lung cancer cells and the underlying mechanism
   Yu Yang et al, 2017 CrossRef
3. Quercetin ameliorates kidney injury and fibrosis by modulating M1/M2 macrophage polarization
   Hong Lu et al, 2018, Biochemical Pharmacology CrossRef
4. Quercetin inhibits kidney fibrosis and the epithelial to mesenchymal transition of the renal tubular system involving suppression of the Sonic Hedgehog signaling pathway
   Xianghua Liu et al, 2019, Food Funct. CrossRef
5. Hyperoside protects against heart failure-induced liver fibrosis in rats
   Xiao Guo et al, 2019, Acta Histochemica CrossRef
6. Prophylactic effects of quercetin and hyperoside in a calcium oxalate stone forming rat model
   Wei Zhu et al, 2014, Urolithiasis CrossRef
7. You-gui Pill ameliorates renal tubulointerstitial fibrosis via inhibition of TGF-β/Smad signaling pathway
   Li Wang et al, 2015, Journal of Ethnopharmacology CrossRef
8. Protective effect of hyperoside on cardiac ischemia reperfusion injury through inhibition of ER stress and activation of Nrf2 signaling
   Jia-Yin Hou et al, 2016, Asian Pacific Journal of Tropical Medicine CrossRef
9. Hyperoside reduces albuminuria in diabetic nephropathy at the early stage through ameliorating renal damage and podocyte injury
   Jisheng Zhang et al, 2016, J Nat Med CrossRef
10. Hyperoside alleviates adriamycin-induced podocyte injury via inhibiting mitochondrial fission
    Zhuyun Chen et al, 2017, Oncotarget CrossRef
11. Plumula Nelumbinis: A Review of Traditional Uses, Phytochemistry, Pharmacology, Pharmacokinetics and Safety
    Sixuan Chen et al, 2020, Journal of Ethnopharmacology CrossRef
12. Fu-Fang-Jin-Qian-Cao herbal granules protect against the calcium oxalate-induced renal EMT by inhibiting the TGF-β/smad pathway
    Wen-Rui Liu et al, 2020, Pharmaceutical Biology CrossRef
13. Qian Yang Yu Yin Granule Improves Renal Injury of Hypertension by Regulating Metabolic Reprogramming Mediated by HIF-1α/PKM2 Positive Feedback Loop.
    Lichao Qian et al, 2021, Front Pharmacol CrossRef
14. Therapeutic and delivery strategies of phytoconstituents for renal fibrosis
    Huan Xu et al, 2021, Advanced Drug Delivery Reviews CrossRef
15. Therapeutic Approaches Targeting Proteostasis in Kidney Disease and Fibrosis
    Jia-Huang Chen et al, 2021, IJMS CrossRef
16. Hyperoside: A Review of Its Structure, Synthesis, Pharmacology, Pharmacokinetics and Toxicity
    Sijin Xu et al, 2022, Molecules CrossRef
17. Hyperoside: a review of pharmacological effects
    Qi Li et al, 2022, F1000Res CrossRef
18. Hyperoside Inhibits Endometrial Fibrosis and Inflammation by Targeting TGF-β/Smad3 Signaling in Intrauterine Adhesion Rats
    Zhengyan Zhu et al, 2022, Rev. Bras. Farmacogn. CrossRef
19. Quercetin prevents hepatic fibrosis by inhibiting hepatic stellate cell activation and reducing autophagy via the TGF-β1/Smads and PI3K/Akt pathways.
    Liwei Wu et al, 2017, Sci Rep CrossRef
20. Hyperoside attenuates Cd-induced kidney injury via inhibiting NLRP3 inflammasome activation and ROS/MAPK/NF-κB signaling pathway in vivo and in vitro
    Ziyin Li et al, 2023, Food and Chemical Toxicology CrossRef
21. Flavonoids-mediated TLR4 Inhibition as a Promising Therapy for Renal Diseases
    Ayman M. Mahmoud et al, 2023, CCHTS CrossRef
22. Potential of Plant-Derived Compounds in Preventing and Reversing Organ Fibrosis and the Underlying Mechanisms
    Patrícia dos Santos Azeredo et al, 2024, Cells CrossRef
23. Quercetin supplementation prevents kidney damage and improves long‐term prognosis in hypertensive patients
    Yawei Zheng et al, 2024, Phytotherapy Research CrossRef